CrystalGenomics Announces Positive Phase IIa Results For Osteoarthritis Study Of CG100649

Podiatry Arena CrystalGenomics Announces Positive Phase IIa Results For Osteoarthritis Study Of CG100649

Welcome to the Podiatry Arena forums, for communication between foot health professionals about podiatry and related topics.

You are currently viewing our podiatry forum as a guest which gives you limited access to view all podiatry discussions and access our other features. By joining our free global community of Podiatrists and other interested foot health care professionals you will have access to post podiatry topics (answer and ask questions), communicate privately with other members (PM), upload content, view attachments, receive a weekly email update of new discussions, earn CPD points and access many other special features. Registered users do not get displayed the advertisments in posted messages. Registration is fast, simple and absolutely free so please, join our global Podiatry community today!

If you have any problems with the registration process or your account login, please contact contact us.

CrystalGenomics Announces Positive Phase IIa Results For Osteoarthritis Study Of CG100649

Submit Thread >

< Submit Thread

Thread Tools

Display Modes

23rd December 2008, 05:30 AM

RSSFeedBot RSSFeedBot is offline

I, Robot

About:

Join Date: Jul 2008

Posts: 10,134

Join Date: Jul 2008

Marketplace reputation 0% (0)

CPD Points: 1

Thanks: 0

Thanked 22 Times in 22 Posts

CrystalGenomics Announces Positive Phase IIa Results For Osteoarthritis Study Of CG100649

Podiatry Arena members do not see these ads

CrystalGenomics, Inc. (Seoul, Korea) and CG Pharmaceuticals, Inc. (Emeryville, CA) announced positive results from a Phase IIa osteoarthritis (OA) study of the efficacy and safety of a next-generation NSAID, CG100649. The CG100649 treatment group met the primary efficacy endpoint by demonstrating a clinically and statistically significant change in the WOMAC(TM) OA score from baseline to Day 21 (p=0.010) compared to placebo.

More...

Sponsored Links

« Previous Thread | Next Thread »

Thread Tools
Show Printable Version Email this Page
Display Modes
Linear Mode Switch to Hybrid Mode Switch to Threaded Mode

Posting Rules
You may not post new threads You may not post replies You may not post attachments You may not edit your posts	vB code is On Smilies are On [IMG] code is On HTML code is On

Forum Jump

Translate This Page

Similar Threads

Thread	Thread Starter	Forum	Replies	Last Post
Forest Laboratories, Inc. And Cypress Bioscience, Inc. Announce Positive Results Of Phase III Study Of Milnacipran For The Management Of Fibromyalgia	RSSFeedBot	Latest Rheumatology News	0	9th December 2008 05:20 AM
Results From The First And Largest Collaborative Study Confirm Role Of Enbrel® In Psoriatic Arthritis	RSSFeedBot	Latest Rheumatology News	0	4th December 2008 10:40 AM
Non- Steroidal Combination Drug To Treat Psoriasis - Positive Phase 2b Results Showing Efficacy And Synergy DPS-101	RSSFeedBot	Latest Dermatology News	0	4th November 2008 02:21 PM
BioCryst Reports Results From BCX-4208 Phase IIa Trial In Subjects With Psoriasis	RSSFeedBot	Latest Dermatology News	0	5th September 2008 07:01 AM

New To Site?	Need Help?
Register to Participate View Forum Leaders Contact Us	Frequently Asked Questions Did you forget your password? Mark Forums Read

Finding your way around:

Browse the forums.

Search the site.

Browse the tags.

Search the tags.

All times are GMT -7. The time now is 04:35 PM.

User Name		Remember Me?
Password